Literature DB >> 11453034

TGFbeta1 and TGFbeta2 mRNA and protein expression in human bone samples.

S Hering1, E Isken, C Knabbe, J Janott, C Jost, A Pommer, G Muhr, H Schatz, A F Pfeiffer.   

Abstract

Transforming growth factor beta is one of the most abundant growth factors stored in bone. It is known as a potent regulator of osteoblast proliferation and differentiation as well as of production extracellular matrix. We established a highly specific RT-PCR in combination with HPLC for detection and quantification of TGFbeta1 and TGFbeta2 mRNA expression in 89 human bone samples. Levels of TGFbeta1 protein ranged between 27 and 580 ng/g bone (mean 188 +/- 15 ng/g; n=75) and for TGFbeta2 between 7.2 and 35 ng/g bone (mean 14.3 +/- 2.1 ng/g; n=57). TGFbeta1 and TGFbeta2 protein concentrations and TGFbeta isoform mRNA expression in bone were not significantly different between the sexes. TGFbeta isoform mRNA expression as well as protein content in bone declined age dependently. TGFbeta1 and TGFbeta2 protein and mRNA expression were different in bone samples from different sites of the skeleton indicating in part the regulation by mechanical stimuli. In contrast to TGFbeta1, TGFbeta2 mRNA expression was significantly enhanced in osteoarthritic bone compared to unaffected bone. These data are in concordance to previous results concerning the expression of TGFbeta3 in bone. In conclusion, the data suggest distinct patterns' of expression of the TGFbeta isoforms under physiological and pathological conditions in bone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453034     DOI: 10.1055/s-2001-15109

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  25 in total

Review 1.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

2.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

3.  TGF-β regulates sclerostin expression via the ECR5 enhancer.

Authors:  Gabriela G Loots; Hansjoerg Keller; Olivier Leupin; Deepa Murugesh; Nicole M Collette; Damian C Genetos
Journal:  Bone       Date:  2011-12-02       Impact factor: 4.398

Review 4.  Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling.

Authors:  Janet L Crane; Xu Cao
Journal:  J Clin Invest       Date:  2014-02-03       Impact factor: 14.808

Review 5.  Genetic causes and mechanisms of Osteogenesis Imperfecta.

Authors:  Joohyun Lim; Ingo Grafe; Stefanie Alexander; Brendan Lee
Journal:  Bone       Date:  2017-02-15       Impact factor: 4.398

6.  Low transforming growth factor-beta1 serum levels in idiopathic male osteoporosis.

Authors:  B Akinci; F Bayraktar; A Saklamaz; T Demir; S Yener; A Comlekci; M A Ozcan; L Kebapcilar; F Yuksel; S Yesil
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

7.  Lentiviral delivery of biglycan promotes proliferation and increases osteogenic potential of bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Bo Wu; Xu Ma; Damu Zhu; Ye Liu; Zhuqing Sun; Suyuan Liu; Bing Xue; Mingchang Du; Ximeng Yin
Journal:  J Mol Histol       Date:  2013-03-17       Impact factor: 2.611

8.  IL-1beta inhibits TGFbeta in the temporomandibular joint.

Authors:  W H Lim; J Toothman; J H Miller; R H Tallents; S M Brouxhon; M E Olschowka; S Kyrkanides
Journal:  J Dent Res       Date:  2009-06       Impact factor: 6.116

9.  A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.

Authors:  Julia N Cheng; Jennifer B Frye; Susan A Whitman; Andrew G Kunihiro; Ritu Pandey; Janet L Funk
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

10.  Cancellous bone properties and matrix content of TGF-beta2 and IGF-I in human tibia: a pilot study.

Authors:  Yener N Yeni; X Neil Dong; Bingbing Zhang; Gary J Gibson; David P Fyhrie
Journal:  Clin Orthop Relat Res       Date:  2009-05-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.